Found 17 matching trials
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) N/A To evaluate whether the combination of clinicopathological factors and the ...
Show More Location
Arthur J.E. Child Comprehensive Cancer Centre
Learn More & Join Trial
Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer N/A Oncotype DX® is likely to become more widely used in Europe as well as in S...
Show More Location
Kantonsspital Baden
Learn More & Join Trial
(Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer N/A This study is a multi-center BCCA study that evaluates the impact of the On...
Show More Location
BC Cancer Agency - Vancouver Centre
Learn More & Join Trial
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer NA This randomized pilot clinical trial studied whether the Oncotype DX gene e...
Show More Location
Washington Cancer Institute
Learn More & Join Trial
Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study N/A The study aims to evaluate the distribution of the Oncotype DX RS® genomic ...
Show More Location
IRCCS Ospedale San Raffaele
Learn More & Join Trial
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) PHASE3 This randomized phase III trial studies the best individual therapy for wom...
Show More Status
Active Not Recruiting
Location
Northeast Alabama Regional Medical Center
Learn More & Join Trial
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score PHASE2 Multiple neoadjuvant endocrine trials demonstrate that women with good prog...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer PHASE2 This study aims to utilize a novel biomarker-driven approach to guide neoad...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE) PHASE3 Young HOPE/JCOG2402 is a multicenter, randomized phase III study designed t...
Show More Location
Akita University Hospita
Learn More & Join Trial
Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol N/A The purpose of this study is to retrieve tissue samples from individuals wi...
Show More Location
Multiple Locations
Learn More & Join Trial